share_log
Moomoo 24/7 ·  Apr 22 17:04
Theriva Biologics Shares Are Trading Higher After the Company Announced It Will Present Preclinical Data for the Potential Synergy of VCN-01 and First-line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment